MTM(SH:688029) Zheng Quan Zhi Xing·2025-08-17 16:11Core Viewpoint - The major shareholder, Shenzhen Zhongke Investment Co., Ltd. (Zhongke Investment), plans to reduce its stake in Nanwei Medical Technology Co., Ltd. due to personal funding needs, with a total reduction of up to 3,756,948 shares, representing no more than 2% of the company's total shares [1][2][3] Shareholder Information - As of the announcement date, Zhongke Investment holds 41,752,818 shares, accounting for 22.2270% of the total share capital of Nanwei Medical [1][2] - The shares held by Zhongke Investment were acquired prior to the company's initial public offering (IPO) and through capital reserve conversion in 2022 [1][2] Reduction Plan Details - The reduction will be executed through both centralized bidding and block trading methods, with a maximum of 1,878,474 shares to be sold via centralized bidding within 90 days after the announcement [1][2] - The planned reduction period is from September 9, 2025, to December 7, 2025 [3] Compliance and Regulations - Zhongke Investment has been registered with the Asset Management Association of China and complies with the regulations regarding the reduction of shares held by venture capital fund shareholders [2] - The reduction does not affect the company's control structure or operational continuity [4]